CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hunan Jingfeng Pharmaceutical Co Ltd Company Snapshot
Hunan Jingfeng Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hunan Jingfeng Pharmaceutical Co Ltd with three other companies in this sector in China: Jiuzhitang Company Limited (2016 sales of 2.67 billion Chinese Renmimbi [US$388.15 million] of which 91% was Pharmacuetical Industry), Jilin Aodong Medicine Industry (Group) Co., Ltd. (2.74 billion Chinese Renmimbi [US$397.21 million] of which 97% was Pharmaceutical Manufacturing), and Chengdu Kanghong Pharmaceuticals Group Co Ltd (2.54 billion Chinese Renmimbi [US$368.75 million] of which 100% was Pharmaceutical Manufacturing).

Sales Analysis. Hunan Jingfeng Pharmaceutical Co Ltd reported sales of 2.64 billion Chinese Renmimbi (US$383.32 million) for the year ending December of 2016. This represents an increase of 7.4% versus 2015, when the company's sales were 2.46 billion Chinese Renmimbi. Sales at Hunan Jingfeng Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 1,799%). Sales of Other Operation saw an increase that was more than double the company's growth rate: sales were up 241.5% in 2016, from 4.37 million Chinese Renmimbi to 14.94 million Chinese Renmimbi. Hunan Jingfeng Pharmaceutical Co Ltd also saw significant increases in sales in Services (up 22.4% to 69.90 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hunan Jingfeng Pharmaceutical Co Ltd
  Stock Performance Chart for Hunan Jingfeng Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 8.21
(Figures in Chinese Renmimbi)
1 Week 4.3%   13 Weeks -9.7%  
4 Weeks -17.2%   52 Weeks -22.9%  
 
Hunan Jingfeng Pharmaceutical Co Ltd Key Data:
  Ticker: 000908 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 2,640,291,792
(Year Ending Jan 2017).
Employees: 3,198
  Currency: Chinese Renmimbi Market Cap: 7,222,947,422
  Fiscal Yr Ends: December Shares Outstanding: 879,774,351
  Share Type: A Gu Closely Held Shares: 488,069,422
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.